Several inhibitors such as rapamycin, PP242, and AKTi-1/2 regulate the phosphorylation level of HNRNP family molecules by targeting the PI3K-AKT-mTOR axis, thereby inhibiting the proliferation, migration, and survival of cancer cells. Here, AKT1 is linked to cancer.